This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|Founder||Lubert Stryer, Paul Nevsky|
|Fate||Acquired by Firmenich|
Senomyx was an American biotechnology company that developed food additives. The company claimed to have "reverse engineered" human taste and aroma receptors. On 17 Sept 2018, private Swiss company Firmenich completed the acquisition of Senomyx.
Senomyx was founded by prominent biochemist Lubert Stryer in 1999. In May 2001, Stryer returned to his professorship at Stanford University and resigned from Senomyx, but continues to be the Chairman of the Scientific Advisory Board.
Around year 2001, Senomyx patented several flavour enhancers by using "proprietary taste receptor-based assay systems", which have been previously expressed in human cell culture, in HEK293 cells. HEK293 cells are a cell line widely used in biological and medical research, immortalised through a genetic modification removed from the original human embryonic kidney cells taken from a healthy, aborted human fetus in the early 1970s.
Senomyx's products work by amplifying the intensity of flavors. Because very small amounts of the additive are used (reportedly less than one part per million) Senomyx has no obligation to report their ingredients to the consumer. Senomyx products fall under the broad category of "artificial flavors." For the same reason, the company's chemicals have not undergone the FDA safety approval. Senomyx's MSG-enhancer gained the Generally Recognized as Safe (GRAS) status from the Flavor and Extract Manufacturers Association, an industry-funded organization, in less than 18 months,"received a positive review by the Joint FAO/WHO Expert Committee on Food Additives, which determined that there were no safety concerns with the use of the Company's savory flavor ingredients in foods. The positive assessment by JECFA is expected to expedite regulatory approvals in a number of countries, particularly those that do not have independent regulatory approval systems."
- Schultz, SA Editor Clark (17 September 2018). "Firmenich to acquire Senomyx". Seeking Alpha. Retrieved 18 September 2018.
|first1=has generic name (help)
- Li, X; Staszewski, L; Xu, H; Durick, K; Zoller, M; Adler, E (April 2002). "Human receptors for sweet and umami taste". Proc. Natl. Acad. Sci. U.S.A. 99 (7): 4692–6. Bibcode:2002PNAS...99.4692L. doi:10.1073/pnas.072090199. PMC 123709. PMID 11917125.
- Vaccines and Related Biological Products Advisory Committee Meeting, p.81 , Center for Biologics Evaluation and Research, May 16, 2001
- Brumpton, Harry (12 June 2018). "Senomyx shareholder pushes for change at flavor maker". Reuters. Retrieved 14 June 2021.